A61P 33 - Antiparasitic agents

Patents for A61P 33 - Antiparasitic agents (21,787)
11/2004
11/04/2004	US20040220055 Benzamidoacetonitriles and their use as antiparastics
11/04/2004	US20040219672 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells
11/04/2004	US20040219201 Tempamine compositions and methods of use
11/04/2004	US20040219181 Sustained release drug delivery devices with coated drug cores
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471818A2 Methods and compositions for treating hematological disorders using 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 or 13249 molecules
11/03/2004	CN1543508A Test systems and the use thereof for identifying and characterizing compounds
11/03/2004	CN1543351A Method for enhancing the effectiveness of cancer therapies
11/03/2004	CN1173988C Resticidal macrolides
11/03/2004	CN1173737C Application of Hepcidin in pharmacy
11/02/2004	US6812241 Nitrogen-containing heterocycles having parasiticidal properties
11/02/2004	US6812224 Phosphorous organic compounds and their use
11/02/2004	CA2317131C Novel erythromycin derivatives
10/2004
10/28/2004	WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004	WO2004078099A3 Compositions and methods for the generation of protective immune response against malaria
10/28/2004	WO2004069806A3 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
10/28/2004	US20040214782 caused by infection from Eimeria bovis, Eimeria zuernii or E. aubernensis; administering macrolide antibiotics, azalide class, such as tilmicosin
10/28/2004	US20040214172 Sheeplice, bovicola ovis, allergen treatment
10/28/2004	US20040213799 Boosting priming composition with nonreplicating and/or replication impaired strains of poxvirus vectors; forming human immunodeficiency virus inhibitors
10/28/2004	US20040213797 Conjugates for the modulation of immune responses
10/28/2004	CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling
10/27/2004	EP1471150A2 Plasmodium falciparum antigens inducing protective antibodies
10/27/2004	EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
10/27/2004	EP1470249A2 Effectors of innate immunity
10/27/2004	EP1470223A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
10/27/2004	EP1470112A1 Substituted pyridazinones as inhibitors of p38
10/27/2004	EP1470103A1 Amidoacetonitrile derivatives
10/27/2004	EP1469845A2 Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases
10/27/2004	EP1469809A2 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same
10/27/2004	CN1541097A 2-amino-4, 5-trisubstituted thiazolyl derivatives
10/27/2004	CN1541090A Prepn. of sustained release pharmaceutical compsn.
10/27/2004	CN1172947C 4'-substituted-9-deoxo-9A-AZA-9A-homoerythromycin a derivatives
10/27/2004	CN1172929C Substituted indoles for modulating NFKB activity
10/26/2004	US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
10/26/2004	US6809090 Nitrogen monoxide synthase and/or lipidic peroxidation inhibitors
10/26/2004	US6809080 Useful as antibacterial and antiprotozoal agents in mammals, including man, as well as in fish and birds.
10/26/2004	US6808710 Contacting cell expressing pd-1 with binding agent; genetic transduction of negative signal
10/26/2004	CA2418634C Pharmaceutical compositions of tizoxanide and nitazoxanide
10/26/2004	CA2316919C Novel macrolides
10/21/2004	WO2004089917A2 Process for resolving 2,4-diamino-3,6-dihydro-1,3,5-triazines, useful for the treatment of disorders associated with insulin resistance syndrome
10/21/2004	WO2004089108A1 Food supplement for animals, especially poultry
10/21/2004	WO2004043428A3 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/21/2004	WO2003027266A3 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
10/21/2004	US20040210052 Efficient synthesis of 5-heteroatom-containing-pyrazoles
10/21/2004	US20040209950 3-(substituted phenoxy)-2-methyl-2-(haloalkoxybenzoylamino)propionitrile derivatives; especially for treating helminths, in warm-blooded productive livestock and domestic animals.
10/21/2004	US20040209868 Substituted indoles
10/21/2004	US20040209826 Diphosphate salt of a "4" - substituted-9-deoxo-9 A - AZA - homoerythromycin derivatives and its pharmaceutical composition
10/21/2004	US20040208851 Immunization by inoculation of DNA transcription unit
10/21/2004	CA2521879A1 Process for resolving amines that are useful for the treatment of disorders associated with insulin resistance syndrome
10/20/2004	EP1468098A2 Method of inhibiting pathogenicity of infectious agents
10/20/2004	EP1468022A1 Novel monoclonal antibody and nematode larval antigens
10/20/2004	EP1468019A2 Secreted protein
10/20/2004	EP1468018A2 Leptin proteins
10/20/2004	EP1467969A2 Dna minor groove binding compounds
10/20/2004	EP1467744A2 Aqueous compositions containing metronidazole
10/20/2004	EP1467742A1 Use of alkylphosphocholines for the preventative treatment of protozoan diseases
10/20/2004	EP1467622A2 Mitocidal compositions and methods
10/20/2004	EP1212337B1 Pesticidal macrolides
10/20/2004	EP1091740B1 Semi-solid aqueous preparations for oral applications of toltrazuril sulphone
10/20/2004	CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
10/14/2004	US20040204481 Activation of natural killer cells by adenosine A3 receptor agonists
10/14/2004	US20040204436 Imidazonaphthyridines
10/14/2004	US20040204368 Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient
10/14/2004	US20040204355 alpha 7 receptor is the alpha -bungarotoxin sensitive receptor that influences the release of proinflammatory cytokines from macrophages
10/14/2004	US20040203099 Conjugate of a transport protein and a protein for modulation of notch signalling
10/14/2004	US20040202728 Method for the destruction of oocysts
10/14/2004	US20040202667 also use in the development of antimalarial drugs and antibodies directed against these Plasmodium proteins.
10/13/2004	EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors
10/13/2004	EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy
10/13/2004	EP1465899A1 Trioxane derivatives
10/13/2004	EP1465870A2 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same
10/13/2004	EP1465648A1 Pediculicidal compound
10/13/2004	EP1465625A2 Solubilized topoisomerase poisons
10/13/2004	EP1301188B1 Anthelmintic agents for preventing parasitic infections in humans and animals iii
10/13/2004	CN1537111A Urea substituted imidazoquinolines
10/13/2004	CN1537000A Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists
10/13/2004	CN1536988A Sustained-release delivery system
10/13/2004	CN1170528C Utilization of inhibitors of KQT1 channel in order to produce medicament for treating diseases which are caused by parasitic helminths and actoparasites
10/12/2004	US6803455 Inhibitors of nucleoside metabolism
10/07/2004	WO2004084922A1 Infection inhibitor for fishes and shellfishes
10/07/2004	WO2004084645A2 Use of allicin as preservative, as disinfectant, as antimicrobial or as biocidal agent
10/07/2004	WO2004072086A3 Antiparasitic terpene alkaloids
10/07/2004	WO2003076446A8 Antiparasitic artemisinin derivatives (endoperoxides)
10/07/2004	US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
10/07/2004	US20040198688 for treatment of atopic conditions (dermatitis, allergies); point mutations
10/07/2004	US20040198651 Secreted proteins
10/07/2004	US20040197349 Methods and reagents for vaccination which generate a CD8 T cell immune response
10/07/2004	US20040197345 Prostate derived Ets factor
10/07/2004	CA2520533A1 Allicin
10/06/2004	EP1463756A2 Secreted proteins
10/06/2004	EP1463405A2 Hair removal and animal husbandry method
10/06/2004	EP1202743B1 Pharmaceutical and cosmetic compositions comprising cod serine proteases and their pharmaceutical and cosmetic use
10/06/2004	EP0869810B1 Cyclosporin-containing soft capsule preparations
10/06/2004	EP0808309B1 Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
10/06/2004	CN1535314A Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof
10/06/2004	CN1533770A Saspension injection containing benzimidazole kind vermifuge
10/05/2004	US6800615 Antihelminthic anthraquinones and method of use thereof
10/05/2004	US6800614 Produced by culturing saccharopolyspora species lw107129 (nrrl 30141); insecticidal and acaricidal activity; useful intermediates for preparing spinosyn analogs
10/05/2004	US6800613 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
09/2004
09/30/2004	WO2004028564A3 Treatment of pathologies which escape the immune response, using optimised antibodies

1 ... 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 ... 218